Business Context and Reporting Period
Intercure Ltd., a foreign private issuer based in Herzliya, Israel, filed this Form 6-K on December 20, 2024. The filing discloses a significant capital raise event announced on December 19, 2024, aimed at supporting the recovery of the Company's Nir Oz Facility.
Key Financial Metrics and Capital Structure
The filing details a private placement and a bank loan commitment rather than historical operating results.
- Private Placement Proceeds: Secured commitments of NIS 66 million (approx. USD 18.2M), with potential to increase to NIS 107 million (approx. USD 29.8M) including warrant exercise.
- Share Issuance: 7,349,896 ordinary shares issued at NIS 4.83 (approx. USD 1.34) per share.
- Warrants: Warrants issued to purchase up to 7,349,896 additional shares at an exercise price of NIS 5.70 (approx. USD 1.58), expiring in four years.
- Bank Loan: Binding commitment for a loan of NIS 30 million (approx. USD 8.3M) for a term of up to 24 months.
- Investors: Includes CEO Alexander Rabinovich and existing shareholders Yaron Yakobi and Tzahi Hagag, who will each hold more than 5% of issued share capital post-investment.
The filing text does not provide clear values for revenue, profit, cash flow, margins, or existing debt levels.
Material Changes
The primary material change is the dilution of existing shareholders through the issuance of new ordinary shares and warrants. The share price for the private placement (NIS 4.83) represents a premium over the opening price on the Tel Aviv Stock Exchange on December 16, 2024 (NIS 4.81). The transaction is subject to shareholder approval and other closing conditions.
Outlook, Risks, and Contingencies
Management Commentary: The funding is explicitly intended to support the recovery of the Nir Oz Facility. The securities are restricted under Nasdaq rules and have not been registered under the Securities Act of 1933.
Risks and Contingencies:
- Transaction Completion: The private placement and loan are subject to closing conditions, including shareholder approval.
- Geopolitical Factors: Risks include the impact of security events in Israel, the war in Israel, and the war in Ukraine.
- Regulatory Environment: Risks related to changes in U.S. and international regulatory landscapes regarding cannabis.
- Market Conditions: General economic conditions and public perception of the cannabis industry.
Investor Verification Checklist
- Confirm the final closing of the private placement and the bank loan, as both are subject to conditions.
- Verify the extent of shareholder dilution resulting from the issuance of 7,349,896 new shares and associated warrants.
- Monitor the status of the Nir Oz Facility recovery and the allocation of the raised funds.
- Review the Company's most recent Form 20-F for detailed risk factors and historical financial data not included in this filing.